Hui Wang

Dr. Hui Wang


Research Focus & Metrics

Academic Career Length

3Years (2024-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
17 July 2024 in Heliyon
Verified
Journal Article
Open access
HWHui Wang
Hui Wang
HSHui Sun
Hui Sun
JSJinping Sun
Jinping Sun
This study examines serum calcium levels and in-hospital mortality in patients with sepsis, a subject with contradictory findings in the existing literature. This retrospective cohort study utilized data from the MIMIC-IV database, focusing on adult patients diagnosed with sepsis between 2008 and 2019. The serum calcium levels were taken as the highest value within the first 24 h of Intensive Care Unit (ICU) admission. We performed Cox proportional hazards regression analyses in multivariable-adjusted models to investigate the association between serum calcium levels and in-hospital mortality. Restricted cubic spline functions were used to assess the nonlinear relationship, and threshold effect analysis was conducted to identify potential inflection points. A total of 18,546 patients with sepsis were included in the study, and an in-hospital mortality rate of 16.9 % (3,126 out of 18,546) was obtained. Furthermore, a U-shaped relationship was observed between serum calcium concentrations and in-hospital mortality, with the lowest point at approximately 8.23 mg/dL. Hazard ratios were calculated as 0.75 (95 % CI: 0.67-0.85, P < 0.001) on the left side and 1.10 (95 % CI: 1.04-1.16, P < 0.001) on the right side of the inflection point. Sensitivity analyses corroborated these results. The research identified a U-shaped correlation between serum calcium concentrations and in-hospital mortality rates among patients with sepsis, underscoring the importance of serum calcium monitoring in this patient population upon hospital admission.

17 July 2026 in Scientific Reports
Verified
Journal Article
Open access
PDF file
HWHui Wang
Hui Wang
Background The prognostic value of Cockcroft-Gault estimated creatinine clearance (CG-CrCl) in critically ill cerebrovascular disease (CVD) patients is unclear. Methods This retrospective cohort study included 8,732 adults from MIMIC-IV. CG-CrCl was examined continuously and by quartiles. Primary outcome was 30-day mortality; secondary outcomes were 90-day and 365-day mortality. Multivariable Cox models, restricted cubic splines, and two-piecewise linear regression assessed associations. Results Overall 30-day, 90-day, and 365-day mortality rates were 17.6%, 22.2%, and 28.8%, respectively. In fully adjusted models, each 1-standard deviation (SD; 45.46 mL/min) decrease in CG-CrCl was independently associated with increased mortality risk (30-day: HR 1.35, 95% CI 1.25–1.45; 90-day: HR 1.32, 95% CI 1.24–1.41; 365-day: HR 1.31, 95% CI 1.24–1.39). A significant nonlinear threshold effect was identified: the association became pronounced only below inflection points of 119.66, 114.84, and 114.89 mL/min for 30-, 90-, and 365-day mortality, respectively. Adding CG-CrCl did not significantly improve discrimination at any time point (all DeLong P > 0.05). Conclusion CG-CrCl is independently associated with short- and long-term mortality in critically ill CVD patients with a nonlinear threshold effect, suggesting it may serve as a readily available risk marker worthy of further validation.

24 July 2026 in Scientific Reports
Verified
Journal Article
Open access
PDF file
HWHui Wang
Hui Wang
XDXiaojun Ding
Xiaojun Ding
XCXuelei Cao
Xuelei Cao
JLJinglei Lv
Jinglei Lv
Critically ill cerebrovascular disease (CVD) patients face high mortality, yet modifiable prognostic factors remain underexplored. The triglyceride-glucose (TyG) index has emerged as a surrogate marker of insulin resistance, but its association with mortality in neurocritical care and its interaction with diabetes status remain unclear. This retrospective cohort study analyzed 2,584 CVD adults from the MIMIC-IV database (2008–2019). The TyG index was calculated from admission glucose and triglyceride values. Multivariable Cox models assessed TyG-mortality associations, with interaction and stratified analyses by diabetes status. Outcomes included 30-, 90-, and 365-day all-cause mortality. In the overall cohort, TyG showed no significant association with 30-day (HR 1.15, 95%CI 1.00–1.32) or 365-day mortality (HR 1.11, 95%CI 0.98–1.24), with a borderline association at 90 days (HR 1.14, 95%CI 1.00–1.30). However, diabetes significantly modified this effect (P for interaction = 0.033, 0.004, and 0.005 at 30, 90, and 365 days, respectively). In non-diabetic patients, each TyG unit increment was associated with significantly higher mortality at all time points (30-day: HR 1.25, 95%CI 1.04–1.50; 90-day: HR 1.26, 95%CI 1.07–1.49; 365-day: HR 1.21, 95%CI 1.03–1.40), whereas no association was observed in diabetic patients. Diabetes critically modifies the TyG-mortality relationship in CVD. The TyG index may serve as a prognostic biomarker primarily in non-diabetic patients, suggesting that diabetes-stratified approaches warrant further investigation in neurocritical care.